Bladder Cancer Trial, Recruiting NCT07318051 Sponsor: Natera, Inc. Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07318051
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older.
  • You have been diagnosed with a primary (original, not spread-from-elsewhere) solid tumor cancer that has not yet been treated, in one of these cancer types: breast, lung, muscle-invasive bladder, rectal, pancreatic, ovarian, gastroesophageal (stomach/esophagus), prostate, melanoma (skin), liver, uterine/endometrial, or head and neck cancer.
  • You are suspected (based on imaging/scans) of having pancreatic, endometrial (uterine), bladder, or ovarian cancer that has not yet been confirmed.
  • You are generally well enough to carry out some daily activities — not completely restricted to bed (confirm with trial site).
  • You are able to have blood drawn through a needle in your vein.
  • You are willing to allow leftover tumor tissue from your procedure to be used for research.
  • You are willing and able to follow all the requirements of the study.
  • You have read and signed a consent form before taking part.

Who may not be able to join:

  • You are currently pregnant or breastfeeding.
  • You have been treated for any other cancer within the past year, or you currently have another active cancer — except if you previously had minor skin cancers (squamous cell or basal cell) that were surgically removed.
  • You have already started systemic treatment (such as chemotherapy or other medicines) after surgery.
  • You have already had, or are planning to have, a specific type of blood test called ctDNA testing to check for remaining cancer cells — except if it is being done to help choose your treatment (confirm with trial site).
  • You have a history of a bone marrow or organ transplant.
  • You have serious health conditions that could make it difficult for you to safely participate in the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 650-489-9050

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Natera, Inc.
Registry
ClinicalTrials.gov
Start date
21 July 2025
Est. completion
1 January 2035

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary Outcome - Collection of Blood and Residual Tissue Specimens for Cancer Assay Development

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov